FOLD
Price
$9.43
Change
+$0.07 (+0.75%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
2.81B
39 days until earnings call
ROIV
Price
$11.16
Change
+$0.27 (+2.48%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
8.12B
30 days until earnings call
Ad is loading...

FOLD vs ROIV

Header iconFOLD vs ROIV Comparison
Open Charts FOLD vs ROIVBanner chart's image
Amicus Therapeutics
Price$9.43
Change+$0.07 (+0.75%)
Volume$60.36K
Capitalization2.81B
Roivant Sciences
Price$11.16
Change+$0.27 (+2.48%)
Volume$87.21K
Capitalization8.12B
FOLD vs ROIV Comparison Chart
Loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FOLD vs. ROIV commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOLD is a Hold and ROIV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (FOLD: $9.36 vs. ROIV: $10.89)
Brand notoriety: FOLD and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FOLD: 91% vs. ROIV: 72%
Market capitalization -- FOLD: $2.81B vs. ROIV: $8.12B
FOLD [@Biotechnology] is valued at $2.81B. ROIV’s [@Biotechnology] market capitalization is $8.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOLD’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • FOLD’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOLD’s TA Score shows that 3 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • FOLD’s TA Score: 3 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both FOLD and ROIV are a bad buy in the short-term.

Price Growth

FOLD (@Biotechnology) experienced а -1.06% price change this week, while ROIV (@Biotechnology) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

FOLD is expected to report earnings on May 07, 2025.

ROIV is expected to report earnings on Jun 25, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.12B) has a higher market cap than FOLD($2.81B). FOLD YTD gains are higher at: -0.637 vs. ROIV (-7.946). ROIV has higher annual earnings (EBITDA): 4.15B vs. FOLD (-9.2M). ROIV has more cash in the bank: 5.39B vs. FOLD (250M). ROIV has less debt than FOLD: ROIV (52.7M) vs FOLD (445M). FOLD has higher revenues than ROIV: FOLD (494M) vs ROIV (129M).
FOLDROIVFOLD / ROIV
Capitalization2.81B8.12B35%
EBITDA-9.2M4.15B-0%
Gain YTD-0.637-7.9468%
P/E RatioN/A2.01-
Revenue494M129M383%
Total Cash250M5.39B5%
Total Debt445M52.7M844%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FOLDROIV
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
58%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
64%
MACD
ODDS (%)
Bearish Trend 5 days ago
73%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
68%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 20 days ago
75%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
77%
Bearish Trend 5 days ago
71%
View a ticker or compare two or three
Ad is loading...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with ALDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then ALDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
+0.97%
ALDX - FOLD
44%
Loosely correlated
-4.88%
DNLI - FOLD
40%
Loosely correlated
+0.79%
ROIV - FOLD
37%
Loosely correlated
-1.63%
PRTA - FOLD
37%
Loosely correlated
-0.68%
RCKT - FOLD
37%
Loosely correlated
-6.16%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.63%
IMVT - ROIV
50%
Loosely correlated
-2.46%
ALDX - ROIV
41%
Loosely correlated
-4.88%
DYN - ROIV
40%
Loosely correlated
-4.95%
STOK - ROIV
40%
Loosely correlated
-0.32%
ACLX - ROIV
40%
Loosely correlated
-0.74%
More